TABLE 3.
Multivariate analysis (Cox regression) of factors affecting time to hepatitis C virus recurrence and survival
| Recurrence | expb (95% CI) | P |
|---|---|---|
| Donor age | 1.02 (1.01–1.03) | 0.03 |
| Acute rejection | 2.8 (1.8–4.3) | <0.01 |
| MELD score at transplant | 1.003 (0.9–1.02) | 0.8 |
| Pulse steroids | 0.9 (0.5–1.9) | 0.9 |
| Age at transplant | 1.03 (0.99–1.07) | 0.1 |
| Cold ischemia time | 0.9 (0.99–1.001) | 0.4 |
| Body mass index | 0.9 (0.9–1.004) | 0.08 |
| Recipient sex | 0.9 (0.9–2.7) | 0.4 |
| Race | 0.5 (0.2–1.1) | 0.1 |
| Transplant era | 0.9 (0.6–1.5) | 0.8 |
| Diabetes mellitus | 0.9 (0.5–1.4) | 0.6 |
|
Survival | ||
| Body mass index | 0.9 (0.85–0.99) | 0.04 |
| Donor age | 1.01 (0.99–1.03) | 0.3 |
| Acute rejection | 1.6 (0.6–3.8) | 0.3 |
| MELD score at transplant | 1.007 (0.9–1.04) | 0.7 |
| Pulse steroids | 1.6 (0.6–4.7) | 0.4 |
| Age at transplant | 1.04 (0.9–1.1) | 0.2 |
| Cold ischemia time | 1 (0.99–1.002) | 0.9 |
| Recipient sex | 0.8 (0.3–2) | 0.6 |
| Race | 1.2 (0.3–5.3) | 0.8 |
| Transplant era | 1.4 (0.6–3.1) | 0.4 |
| Diabetes mellitus | 0.9 (0.4–2.03) | 0.7 |
MELD Model for End-stage Liver Disease